Related Experiment Video
Updated: Aug 21, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland
Anna Gzyl1, Ewa Augustynowicz, Daniel Rabczenko
1Department of Sera and Vaccines Evaluation, National Institute of Hygiene, Chocimska Str 24, 00-791 Warsaw, Poland. agzyl@pzh.gov.pl
Insights
Pertussis (whooping cough) vaccine potency in Poland has declined since 1992, potentially explaining the rise in childhood cases. Changes in vaccine production and testing correlate with reduced potency and efficacy.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Poland, like other highly immunized nations, is experiencing a resurgence of pertussis (whooping cough) cases.
- This increase is concerning given high vaccination rates.
Purpose of the Study:
- To investigate potential fluctuations in the potency of the pertussis component of diphtheria-tetanus-pertussis (DTP) vaccines produced in Poland.
- To assess the impact of changes in vaccine production and potency testing procedures on vaccine efficacy.
Main Methods:
- Analysis of Kendrick test results for DTP vaccine lots over a 30-year period.
- Comparison of vaccine potency based on production periods, manufacturers, vaccine strain composition, and reference preparations.
Main Results:
- A significant downtrend in pertussis vaccine potency was observed starting in 1992.
- Reduced potency from 1992-1997 correlated with lower International Units per dose (IOU/dose).
- Variations in vaccine strain composition and reference vaccines influenced potency estimations.
Conclusions:
- Changes in vaccine production and testing procedures have impacted DTP vaccine potency.
- The DTP vaccine produced between 1992-1997 may have had lower relative efficacy.
- This reduced efficacy could contribute to the observed increase in pertussis cases among Polish children aged 5-15.
Abstract:
In Poland, similar to many highly immunized Western countries, a recent increase in cases of pertussis has been observed. This study aims to evaluate the level of potency fluctuations of the pertussis component of Polish-produced DTP vaccine due to the changes having occurred in production and potency testing procedures. We compared the potency of the pertussis component of DTP vaccine lots produced and evaluated in similar periods and with similar production and testing procedures. Records of Kendrick test results performed over a 30-year period were available for analysis. This study confirms the role of different manufacturers, changes in vaccine strain compositions, in-house reference preparations used as reference vaccines in the Kendrick tests, and in mice of single strain sources in the potency values obtained. In addition, the comparisons performed revealed a downtrend in potency levels since 1992. Potency decrease in vaccine lots produced during 1992-1997 has been positively correlated to the lowering of the number of IOU/dose. Strain compositions of the DTP vaccine pertussis component and in-house references have been found to be associated with the fluctuation in potency estimations, and confirmed their crucial role in ensuring vaccine efficacy. Our study reveals that relative efficacy of the DTP vaccine produced in 1992-1997 might be lower than that of vaccines produced in other periods. This might in turn explain the increase in pertussis cases among children aged 5-15 years which is presently being observed in Poland.
Related Concept Videos
Poliomyelitis
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Toxicity Testing in Animals
Diphtheria

